Published prices, deliverables, deadlines. See the price
Founderside
Madhu Desbois, smiling at the camera in a bright room full of tall green plants.

The only advisory practice for early-stage health founders run by an operator who has raised the round and run the company behind it.

For the founder or CEO of a medtech, biotech or healthtech company, from pre-seed to Series A.

How it works

Choose one analysis: Deck, Vision or Operational Structuring. Its price is fixed before you start.

Madhu does the work and hands you the deliverable by the deadline published with it.

Want more? Ongoing support, a monthly retainer or fractional COO days, is available on request.

Light wooden shelves holding neatly labelled document boxes, folders and a small white medical device.

Madhu spent ten years on the operations side of health companies, and has raised from specialised medtech and biotech funds.

Mesdocteurs
COO, 2015 to 2020. Teleconsultation and medical device.
Heloa
General Manager, 2020 to 2026.
Funding
Equity and non-dilutive, from specialised medtech and biotech funds: French, European, international.
Approvals
Deeptech approvals obtained.

Sample

A sample of what lands on your desk

Five sample pages, written to show the shape of the work for a health founder. Each one is an illustration.

Sample · Deck Analysis

Slide 4: the problem

Lead with the clinical pathway.
Put the patient before the market.
Move market size to slide 6.
Let the evidence come first.
One line for competitors.
Replace the grid.
Sample · Vision Analysis

Where the round fits

Specialised health fund
First conversation.
Non-dilutive funding
Alongside the equity, not instead.
Deeptech approval
Worth pursuing early.
Sample · Operations

Who owns what

Founder
Fundraising and product.
Operator
Regulatory file and finance.
Next hire
Quality and regulatory lead.
Sample · Fund prep

Before a fund meeting

  • One-line claim
  • Regulatory path on one slide
  • Use of funds
  • Questions for the fund
Sample · Fund prep

What a fund will ask

Who pays, and who decides?
Answer it in one sentence.
What does approval change?
For patients and for revenue.
What must the next round prove?
Name it before they do.

Fixed-scope analyses, priced before you start

  • Deck Analysisfrom€1,200
  • Vision Analysisfrom€3,500
  • Operational Structuring Analysisfrom€5,500

All prices excl. VAT.

Ongoing support, as a monthly retainer or fractional COO days per month, is available on request.